These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32607691)

  • 1. Apigenin Modulates Dendritic Cell Activities and Curbs Inflammation Via RelB Inhibition in the Context of Neuroinflammatory Diseases.
    Ginwala R; Bhavsar R; Moore P; Bernui M; Singh N; Bearoff F; Nagarkatti M; Khan ZK; Jain P
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):403-424. PubMed ID: 32607691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.
    Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P
    Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell Functions.
    Ginwala R; McTish E; Raman C; Singh N; Nagarkatti M; Nagarkatti P; Sagar D; Jain P; Khan ZK
    J Neuroimmune Pharmacol; 2016 Mar; 11(1):36-47. PubMed ID: 26040501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
    Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
    J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RelB Deficiency in Dendritic Cells Protects from Autoimmune Inflammation Due to Spontaneous Accumulation of Tissue T Regulatory Cells.
    Andreas N; Potthast M; Geiselhöringer AL; Garg G; de Jong R; Riewaldt J; Russkamp D; Riemann M; Girard JP; Blank S; Kretschmer K; Schmidt-Weber C; Korn T; Weih F; Ohnmacht C
    J Immunol; 2019 Nov; 203(10):2602-2613. PubMed ID: 31578269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
    Wang D; Lu Z; Zhang H; Jin SF; Yang H; Li YM; Shi LY
    CNS Neurosci Ther; 2016 Jul; 22(7):558-67. PubMed ID: 27013083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy with costimulatory dendritic cells to control autoimmune inflammation.
    O'Sullivan BJ; Pai S; Street S; An X; MacDonald KP; Wong M; Strutton G; Gerondakis S; Steptoe RJ; de St Groth BF; Hill GR; Thomas R
    J Immunol; 2011 Oct; 187(8):4018-30. PubMed ID: 21900177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZSTK474, a novel PI3K inhibitor, modulates human CD14+ monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis.
    Xue Z; Li W; Wang H; Huang B; Ge Z; Gu C; Liu Y; Zhang K; Yang J; Han R; Peng M; Li Y; Zhang D; Da Y; Yao Z; Zhang R
    J Mol Med (Berl); 2014 Oct; 92(10):1057-68. PubMed ID: 24844601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis.
    Yan Y; Zhang GX; Gran B; Fallarino F; Yu S; Li H; Cullimore ML; Rostami A; Xu H
    J Immunol; 2010 Nov; 185(10):5953-61. PubMed ID: 20944000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A T cell-intrinsic function for NF-κB RelB in experimental autoimmune encephalomyelitis.
    Lalle G; Lautraite R; Voisin A; Twardowski J; Stéphan P; Perrin-Niquet M; Igalouzene R; Soudja SM; Marie JC; Vocanson M; De Silva N; Klein U; Ghosh S; Grinberg-Bleyer Y
    Sci Rep; 2021 Oct; 11(1):19674. PubMed ID: 34608221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chrysin suppresses human CD14(+) monocyte-derived dendritic cells and ameliorates experimental autoimmune encephalomyelitis.
    Zhang K; Ge Z; Xue Z; Huang W; Mei M; Zhang Q; Li Y; Li W; Zhang Z; Zhang Z; Zhang L; Wang H; Cai J; Yao Z; Zhang R; Da Y
    J Neuroimmunol; 2015 Nov; 288():13-20. PubMed ID: 26531689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells.
    Kang HK; Ecklund D; Liu M; Datta SK
    Arthritis Res Ther; 2009; 11(2):R59. PubMed ID: 19405952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells.
    Rojas-Canales D; Krishnan R; Jessup CF; Coates PT
    Clin Exp Immunol; 2012 Mar; 167(3):447-58. PubMed ID: 22288588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1.
    Park JH; Jeong SY; Choi AJ; Kim SJ
    Immunol Lett; 2015 May; 165(1):10-9. PubMed ID: 25794633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells.
    Benkhoucha M; Molnarfi N; Dunand-Sauthier I; Merkler D; Schneiter G; Bruscoli S; Riccardi C; Tabata Y; Funakoshi H; Nakamura T; Reith W; Santiago-Raber ML; Lalive PH
    J Immunol; 2014 Sep; 193(6):2743-52. PubMed ID: 25114100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
    Ge Z; Da Y; Xue Z; Zhang K; Zhuang H; Peng M; Li Y; Li W; Simard A; Hao J; Yao Z; Zhang R
    Exp Neurol; 2013 Mar; 241():56-66. PubMed ID: 23261766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-Reactive Protein Suppresses the Th17 Response Indirectly by Attenuating the Antigen Presentation Ability of Monocyte Derived Dendritic Cells in Experimental Autoimmune Encephalomyelitis.
    Shen ZY; Zheng Y; Pecsok MK; Wang K; Li W; Gong MJ; Wu F; Zhang L
    Front Immunol; 2021; 12():589200. PubMed ID: 33841391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity.
    Schulze-Topphoff U; Shetty A; Varrin-Doyer M; Molnarfi N; Sagan SA; Sobel RA; Nelson PA; Zamvil SS
    PLoS One; 2012; 7(3):e33797. PubMed ID: 22479444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.